Margins of education segment of Q2FY25 looks lowest in last 8 quarters. Can someone help how to read this?
Posts in category All News
US charges against Adani could lead to arrest warrants (22-11-2024)
With the US filing civil and criminal charges against billionaire Gautam Adani and seven others over a multi-million-dollar bribery scheme, a prominent attorney here has said that the case could escalate significantly, potentially leading to arrest warrants and even extradition attempts. Adani, India’s second-richest man, and seven others, including his nephew Sagar Adani, have been charged by the US Department of Justice with paying bribes to unidentified officials of state governments in Andhra Pradesh and Odisha to buy expensive solar power, potentially earning more than $2 billion in profit over 20 years.
Microcap momentum portfolio (22-11-2024)
How do you retrieve daily index values? Is it a manual process? In the video, there didn’t appear to be a formula for the index column. Instead, it seems you simply extended the last week’s Friday value, as shown in the screenshot.
Also, can you take my update on this week (lookback dates 01/12/23 and 24/05/2024)
Based on Ranking:
- STAR
- GRWRHITECH
- WOCKPHARMA
- CHOICEIN
- SUPRIYA
- PGEL
- NEULANDLAB
- TIPSMUSIC
- WABAG
- PRUDENT
- SHILPAMED
- INOXGREEN
- VMART
- NAVA
- ZENTEC
- GANESHHOUC
- OPTIEMUS
- AMIORG
- SANSERA
- KIRLPNU
- BANCOINDIA
- ORCHPHARMA
- MARKSANS
- AVALON
- IIFLSEC
Based on A → Z:
AMIORG*
AVALON*
BANCOINDIA*
CHOICEIN
GANESHHOUC
GRWRHITECH
IIFLSEC
INOXGREEN
KIRLPNU
MARKSANS
NAVA
NEULANDLAB
OPTIEMUS
ORCHPHARMA*
PGEL
PRUDENT
SANSERA
SHILPAMED
STAR
SUPRIYA
TIPSMUSIC
VMART
WABAG
WOCKPHARMA
ZENTEC
Exits: KESORAMIND and SARDAEN exit. GRAVITAS & LTFOOD stay within the top 30 and hence stay.
Entries: AMIORG & AVALON enter. ORCHPHARMA and BANCOINDIA cannot enter as there is no vacancy.
Addictive Learning Technology limited (LAWSIKHO) (22-11-2024)
They gradually reached 10 Cr per month in sales, but you have to understand that it wasn’t at the start of FY. Think it more like 5+6+7+8+9+10 = 45 (Consolidated Numbers which they published)
Mallcom India – Safety Equipment manufacturer (22-11-2024)
Mallcom Q2 FY25 Results, Earnings Quality/Conference Call highlights
Overall, while Mallcom has delivered fair (yoy) top-line growth in Q2 FY25, the decline in EBITDA margin has to be closely watched in coming quarters, although management tried to justify it as aggressive investments in branding, promotion, and expansions. Got to see how these translate into sustained revenue and margin improvements in next few quarters.
Few interesting developments are the launch of website new e-Commerce site that can now cater to both B2C and B2B orders/deliveries, along with revamped e-brochures – domestic and the export brochure (private label). I tried to order few products to my home town in Kerala and the delivery is within in 10 days and has all payment gateway options.
Also, seeing some increased number of expo participations and promotions of product launches in their multiple social media handles, like a recent one on ‘INFERNO’ – flame resistant work wear! Hope these efforts will turn to numbers in medium term. Below are few takeaways from latest Investor presentation and conference calls.
New Product Launches and e-Commerce website launched in Q2 FY25
- A new e-commerce website. This website was launched to cater to both B2B and B2C demand, providing customers with direct access to Mallcom’s range of certified products at list prices.
- A newly designed single-density sole with Docker and Doxle range of shoes having wider toe caps for the Indian market. This launch caters to the evolving demand in the Indian market, where customers are increasingly seeking value-added and user-friendly products.
Metric | Q2 FY25 (INR Mn) | YoY Growth | Margin (%) |
---|---|---|---|
Operating Revenue | 1,291 | 19.2% | N/A |
Total Expenses | 1,133 | 22.0% | N/A |
EBITDA | 158 | 3.0% | 12.24% |
Depreciation | 23 | (23.3)% | N/A |
Finance Cost | 101 | 10.0% | N/A |
Other Income | 21 | N/A | N/A |
Profit Before Tax (PBT) | 145 | 16.9% | N/A |
Tax | 44 | 37.5% | N/A |
Profit After Tax (PAT) | 101 | 9.8% | 7.82% |
Diluted EPS (INR) | 16.19 | 10.4% | N/A |
Insights on Earnings Quality:
- Declining EBITDA Margin: The EBITDA margin declined year-on-year from 14.22% in Q2 FY24 to 12.24% in Q2 FY25. This decline is attributed to higher spending on branding, promotion, and consultancy. While these investments aim to support future growth, their effectiveness and impact on profitability need to be closely monitored.
- Increased Operating Expenses: Total expenses grew at a faster pace (22.0%) compared to operating income (19.2%), contributing to the margin compression. The sustainability of this growth strategy depends on the company’s ability to generate sufficient revenue to offset these higher expenses.
- Inventory Levels: Inventory levels have increased in the first half of FY25. This increase is attributed to supply chain challenges and a strategic decision to maintain buffer stock. While this approach can help mitigate supply disruptions, excessive inventory buildup could tie up working capital and potentially lead to write-downs.
- Reliance on Export Markets: Mallcom generates a significant portion of its revenue from export markets, primarily Europe and Asia. While the company is actively pursuing growth in the domestic market, its exposure to global economic conditions and geopolitical risks should be considered when assessing earnings quality.
- Impact of New Product Launches: Mallcom is launching new products, such as PU gloves and helmets, and expanding into new segments like eye protection. The success of these initiatives will be crucial for driving future revenue growth and maintaining profitability.
Insights from Management Commentary:
-
Management’s commentary suggests a confident outlook for the future, supported by strong demand in both domestic and international markets.
-
The company is actively investing in expansion, new product development, and branding to capture this demand and achieve its ambitious growth targets.
-
Management acknowledges the challenges posed by supply chain disruptions and rising costs, but remains committed to maintaining a healthy margin profile.
As usual Management tried to paint a picture poised for continued growth. The company’s focus on expanding its product portfolio, strengthening its distribution network, and capitalizing on emerging market opportunities positions it well for the future.
Disclaimer: Invested and Biased. Less than 3% of PF, No transactions in last 30 days. Post purely for study purposes. Consult your advisor before any investment decisions.
Addictive Learning Technology limited (LAWSIKHO) (22-11-2024)
In the alpha SME presentation by the promoter, he said that 10 cr per month is possible and already achieved. Wonder why sales is just 40Cr instead of 60 Cr.
Samhi Hotels – Turnaround with Tailwinds (22-11-2024)
Supply of stock at higher rates is a major overhang, as i stated earlier, Samhi is a right candidate for takeover or merger. 230-250 can be achieved easily, we may see large block deals post that rate, let the events unfold in coming future.
Gujarat Themis Biosyn Ltd – Bulk Drugs growth momentum (22-11-2024)
Thanks for sharing this information.